Facioscapulohumeral Muscular Dystrophy (FSHD) Latest Advances

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

What Is in the Myopathy Literature?

Journal: Journal of clinical neuromuscular disease

Published: March 02, 2026

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Journal: Journal of neuromuscular diseases

Published: February 06, 2026

Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.

Journal: Facial plastic surgery & aesthetic medicine

Published: February 04, 2026

Ultrasound Contrast between the Trapezius and Supraspinatus Muscles as a Potentially Specific Finding of Facioscapulohumeral Muscular Dystrophy.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2026

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Journal: Neuromuscular disorders : NMD

Published: January 15, 2026

Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study.

Journal: PeerJ

Published: January 02, 2026

The importance of patient engagement in scientific research on facioscapulohumeral muscular dystrophy.

Journal: Neuromuscular disorders : NMD

Published: December 07, 2025

Measuring health-related quality of life in facioscapulohumeral muscular dystrophy: a COSMIN systematic review and conceptual framework.

Journal: Health and quality of life outcomes

Published: November 26, 2025

A new integrated genetic and transcriptomic approach for investigating DUX4 and DUX4C.

Journal: Journal of human genetics

Published: November 19, 2025

Phase separation of DUX family proteins drives totipotent-like state via 3D genome reorganization and retrotransposon activation.

Journal: Protein & cell

Published: November 19, 2025

Facioscapulohumeral Muscular Dystrophy (FSHD) Latest Advances

Find the Latest Research About Facioscapulohumeral Muscular Dystrophy (FSHD)

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy.

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy.

What Is in the Myopathy Literature?

What Is in the Myopathy Literature?

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.

Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.

Ultrasound Contrast between the Trapezius and Supraspinatus Muscles as a Potentially Specific Finding of Facioscapulohumeral Muscular Dystrophy.

Ultrasound Contrast between the Trapezius and Supraspinatus Muscles as a Potentially Specific Finding of Facioscapulohumeral Muscular Dystrophy.

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats.

Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats.

Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study.

Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study.

The importance of patient engagement in scientific research on facioscapulohumeral muscular dystrophy.

The importance of patient engagement in scientific research on facioscapulohumeral muscular dystrophy.

Measuring health-related quality of life in facioscapulohumeral muscular dystrophy: a COSMIN systematic review and conceptual framework.

Measuring health-related quality of life in facioscapulohumeral muscular dystrophy: a COSMIN systematic review and conceptual framework.

A new integrated genetic and transcriptomic approach for investigating DUX4 and DUX4C.

A new integrated genetic and transcriptomic approach for investigating DUX4 and DUX4C.

Phase separation of DUX family proteins drives totipotent-like state via 3D genome reorganization and retrotransposon activation.

Phase separation of DUX family proteins drives totipotent-like state via 3D genome reorganization and retrotransposon activation.